Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JAKARTA trial in rheumatoid arthritis
NL-OMON51028Recruiting
- Sponsor
- Reade
- Start
- Mar 2022
- Countries
- 1
01
Overview
Open-label trial in rheumatoid arthritis (RA) (2 arms), sponsored by Reade. Primary endpoint: Change in left ventricular function after 1 year of JAK inhibitor treatment. Started Mar 2022; status: recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON51028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51028.